Stocks · US
PFE
XNYS
Pfizer Inc.
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E36.06x
P/B1.83x
P/S2.45x
EPS$0.76
ROE5.09%
ROA2.15%
Dividend yield6.26%
EV/EBITDA9.26x
Debt/Equity0.74
Free cash flow$11.0B
Returns and 52-week range
1W-4.25%
1M-3.34%
3M+14.35%
6M+1.48%
1Y+0.47%
YTD+9.21%
52W high$29.21
52W low$23.62
From 52W high-5.85%
Company
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| 애보트 래브러토리스 | $173.2B | 31.93 | 3.39 | -9.39% |
| 다나허 | $155.5B | 38.84 | 2.96 | +3.83% |
| 길리어드 사이언스 | $179.3B | — | 15.16 | -4.48% |
| 인튜이티브 서지컬 | $143.6B | 45.75 | 7.90 | +10.38% |
| 암젠 | $217.9B | 24.92 | 18.64 | -7.92% |
| Bristol-Myers Squibb Co. | $120.1B | 12.94 | 5.38 | -10.82% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.